2027 年亚太地区术中神经监测市场预测 - COVID-19 影响和按产品（系统、配件和服务）进行区域分析；来源（内包监测和外包监测）；应用（脊柱外科、神经外科、血管外科、耳鼻喉外科、骨科外科和其他外科手术）；模态（运动诱发电位、体感诱发电位、脑电图、肌电图、脑干听觉诱发电位和视觉诱发电位）；和最终用户（医院和门诊手术中心）以及国家/地区
No. of Pages: 128 | Report Code: TIPRE00013992 | Category: Life Sciences
No. of Pages: 128 | Report Code: TIPRE00013992 | Category: Life Sciences
市场介绍
术中神经监测（IONM）是一种大多数外科手术的组成部分。它已被广泛使用，可最大限度地减少手术操作引起的神经系统发病率，识别神经结构，从而预防术后损伤。此类监测的目的是在发生不可逆损伤之前识别脊髓、大脑和周围神经功能的变化。 IONM 采用多种模式，包括运动诱发电位 (MEP)、体感诱发电位 (SSEP)、脑电图 (EEG)、肌电图、脑干听觉诱发电位 (BAEP) 和视觉诱发电位 (VEP)。
市场概况和动态
亚太地区术中神经监测市场预计将从 2019 年的 4.915 亿美元增至 2027 年的 9.1559 亿美元。预计 2019 年至 2027 年该市场将以 8.2% 的复合年增长率增长。神经系统疾病发病率的上升和神经监测领域技术的不断进步是预计推动亚太地区术中神经监测市场增长的主要因素。然而，市场可能会受到预测期内缺乏熟练专业人员等风险因素的影响。
主要细分市场
就产品而言，2019年系统细分市场占据亚太地区术中神经监测市场的最大份额。从来源来看，内源监测细分市场占据了2019年亚太区术中神经监测市场的最大份额。从方式来看，体感诱发电位细分市场占据了2019年亚太区术中神经监测市场的最大份额。从应用来看，脊柱外科细分市场在2019年亚太地区术中神经监测市场中占据最大份额。就最终用户而言，医院细分市场在2019年亚太地区术中神经监测市场中占据最大份额。
主要来源和上市公司
与亚太地区术中神经监测市场报告相关的几个主要一手和二手来源是世界卫生组织 (WHO)、印度品牌股权基金会、大脑基金会等。
购买报告的理由
亚太地区术中神经监测市场细分
按产品
按来源
< span>按模态
按应用
最终用户
< span>按国家/地区
公司简介
Strategic insights for Asia Pacific Intraoperative Neuromonitoring involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2019 | US$ 491.50 Million |
| Market Size by 2027 | US$ 915.59 Million |
| Global CAGR (2019 - 2027) | 8.2% |
| Historical Data | 2017-2018 |
| Forecast period | 2020-2027 |
| Segments Covered |
By 产品
|
| Regions and Countries Covered | 亚太地区
|
| Market leaders and key company profiles |
The regional scope of Asia Pacific Intraoperative Neuromonitoring refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The List of Companies - Asia Pacific Intraoperative Neuromonitoring Market
The Asia Pacific Intraoperative Neuromonitoring Market is valued at US$ 491.50 Million in 2019, it is projected to reach US$ 915.59 Million by 2027.
As per our report Asia Pacific Intraoperative Neuromonitoring Market, the market size is valued at US$ 491.50 Million in 2019, projecting it to reach US$ 915.59 Million by 2027. This translates to a CAGR of approximately 8.2% during the forecast period.
The Asia Pacific Intraoperative Neuromonitoring Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Intraoperative Neuromonitoring Market report:
The Asia Pacific Intraoperative Neuromonitoring Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Asia Pacific Intraoperative Neuromonitoring Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Asia Pacific Intraoperative Neuromonitoring Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Asia Pacific Intraoperative Neuromonitoring Market
